Myoepithelial carcinoma of the arm: a rare soft tissue tumor in an unusual location
Journal of Rare Diseases · 12.03.2026 · 5 (1)
DOI: 10.1007/s44162-026-00176-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rare Diseases, online erschienen am 12.03.2026. Verfasst von Marya Hameed und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Myoepithelial carcinoma (MC) is commonly identified as an aggressive tumor among the pediatric age group. Due to its rarity, it is often misidentified with other soft tissue tumors, causing a delay in management resulting in bad prognosis. Case presentation A 13-year-old child presented with complaints of swelling with tenderness on his left arm above the cubital fossa involving the neurovascular bundle, diagnosed on MRI. Histopathology showed fibromuscular tissue with nests of tumor cells. He was on adjuvant therapy. However, recurrence was visualized on a follow-up scan, and he was further managed with palliative systemic chemotherapy.
Conclusion
ME tumors can go undiagnosed, especially when they are located at an unusual site. A high index of suspicion and familiarity with the tumor’s heterogeneity can improve diagnostic accuracy.
Zitieren
APA
Hameed, M., Shaikh, A. T., & Qureshi, M. F. H. (2026). Myoepithelial carcinoma of the arm: a rare soft tissue tumor in an unusual location. Journal of Rare Diseases, 5(1). https://doi.org/10.1007/s44162-026-00176-4
Vancouver
Hameed M, Shaikh AT, Qureshi MFH. Myoepithelial carcinoma of the arm: a rare soft tissue tumor in an unusual location. Journal of Rare Diseases. 2026;5(1). doi:10.1007/s44162-026-00176-4
BibTeX
@article{Hameed2026,
author = {Hameed, Marya and Shaikh, Areeba Tufail and Qureshi, Muhammad Fazal Hussain},
title = {Myoepithelial carcinoma of the arm: a rare soft tissue tumor in an unusual location},
journal = {Journal of Rare Diseases},
year = {2026},
volume = {5},
number = {1},
doi = {10.1007/s44162-026-00176-4}
}
EUVIMED